Clinical Trial Update: Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating montelukast for gastrointestinal tolerability in patients with relapsing forms of multiple sclerosis treated with Tecfidera. Completed;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Montelukast (Montelukast)
• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2018-07-24